Your SlideShare is downloading. ×
UN Informal Interagency Task Team onSustainable Procurement in the HealthSector (IIATT-SPHS)Volker WelterSenior Procuremen...
UN Informal Interagency Task Teamon Sustainable Procurement in theHealth Sector
Agenda• Introduction of entities involved in the IIATT-SPHS• The issues targeted by the IIATT-SPHS• The opportunity of joi...
Core participantsUN AgenciesUNDPUNFPAUNOPSWHOUNICEFUNEP
Additional participantsPublic SectorStockholm County CouncilCapital Region of DenmarkGerman Federal Environment AgencySwed...
The issues targeted by the IIATT-SPHSThe health sector as an agent and arecipient of environmental problems:– Contributor ...
The issues targeted by the IIATT-SPHSProcurement ofpharmaceuticalsand medical devicesToxicity to theenvironmentGreenhouse ...
The issues targeted by the IIATT-SPHSBreakdown of the NHS Carbon Footprint 2010The pie representsthe proportionaldivide of...
The opportunity for joint UN action• Production, distribution, use and disposal ofpharmaceuticals and medical devices is a...
Interagency Approach: 3 levels• WHO and UNFPA prequalification programmes(medical devices, drugs, condoms)• WHOPES product...
Objectives of the IIATT-SPHS• To develop solid and transparent scientific consensus oncriteria for sustainable procurement...
Strategies of the IIATT-SPHS• In order to accomplish the objectives, the IIATT-SPHS has developed a detailed Route Mapinit...
• Should we bring in the road map?
Virtuous circle of green procurement in thehealth sectorRelease oftoxic productsResourceconsumption(electricity,water)Gree...
Current stage of initiatives• Mapping of existing approaches to:• Environmental criteria in tender processes• Carbon footp...
Concrete initiatives undertaken so far• Carbon footprint assessments:• Pilot projects in Tajikistan and Montenegro• Monthl...
Timeline of future actionsScoping phase (until the end of 2013)• Mobilize a wide range of stakeholders to build consensus ...
Timeline of future actionsDevelopment of a Joint Programming Proposal• UN initiative to integrate most green procurement a...
Main concerns1. Green procurement of pharmaceuticals andmedical products will make the products moreexpensive• Experience ...
Main concerns2. Green procurement of medicines will createmarket imbalances against manufacturingcompanies from developing...
Main concerns3. Sustainable product of medicines will reducethe quality and efficacy of the therapydepriving patients of t...
Main concerns4. Scientific evidence justifying greenprocurement of pharmaceuticals andmedical devices is insufficient• Exi...
Concluding remarksThe IIATT-SPHS targets the emerging environmentalproblems of the health sector:• Green house gas emissio...
Thank you for yourattention
Interagency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health Sector
Upcoming SlideShare
Loading in...5
×

Interagency Approach to Sustainable Procurement in Health Sector

598

Published on

Published in: Technology, Business
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
598
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide
  • UN AGENCIES: Mention that actually the secretariat is managed by UNDP and that they have the major stake into the project
  • Transcript of "Interagency Approach to Sustainable Procurement in Health Sector"

    1. 1. UN Informal Interagency Task Team onSustainable Procurement in the HealthSector (IIATT-SPHS)Volker WelterSenior Procurement AdviserProcurement Support OfficeUNDP Copenhagen
    2. 2. UN Informal Interagency Task Teamon Sustainable Procurement in theHealth Sector
    3. 3. Agenda• Introduction of entities involved in the IIATT-SPHS• The issues targeted by the IIATT-SPHS• The opportunity of joint UN action• The objectives of the IIATT-SPHS• The strategies of the IIATT-SPHS• The current stage of the initiatives• Timeline of future actions• Main concerns• Concluding remarks
    4. 4. Core participantsUN AgenciesUNDPUNFPAUNOPSWHOUNICEFUNEP
    5. 5. Additional participantsPublic SectorStockholm County CouncilCapital Region of DenmarkGerman Federal Environment AgencySwedish Medical Product AgencyNHSand othersPrivate SectorNIRASArupDeloitteand othersNGOsNational Substitution GroupFairtradeChemSecand others
    6. 6. The issues targeted by the IIATT-SPHSThe health sector as an agent and arecipient of environmental problems:– Contributor of greenhouse gas emissions andtoxic chemicals in the environment– Recipient of emerging diseases due to toxicchemicals in the environment and climatechange
    7. 7. The issues targeted by the IIATT-SPHSProcurement ofpharmaceuticalsand medical devicesToxicity to theenvironmentGreenhouse gasemissions
    8. 8. The issues targeted by the IIATT-SPHSBreakdown of the NHS Carbon Footprint 2010The pie representsthe proportionaldivide of the overallGHG emissions andthe graphic is theproportional divideof GHG emissionsdue to procurement
    9. 9. The opportunity for joint UN action• Production, distribution, use and disposal ofpharmaceuticals and medical devices is an importantarea of concern from an environmental point of view• UN agencies (UNDP, WHO, UNFPA, UNICEF, UNOPS)procurement for the health sector represents asizable part of the market (3 billion USD in 2012)• The UN has a critical mass of procurement in somesegments of the market that could help orienting themarket towards more sustainable directions
    10. 10. Interagency Approach: 3 levels• WHO and UNFPA prequalification programmes(medical devices, drugs, condoms)• WHOPES products and manufacturing sitesImpact oninternationalstandards• Mandatory environmental weighting inevaluationProcurementprocedures• Including environmental standards, criteria andcharacteristicsProductspecifications
    11. 11. Objectives of the IIATT-SPHS• To develop solid and transparent scientific consensus oncriteria for sustainable procurement related to the healthsector that would be:• Evidence based• Technically sound• Cost effective• Applicable in countries/suppliers from differentparts of the world• To develop harmonized tools for procurement, capacity-building and the necessary procedures to enable theimplementation, monitoring and evaluation of greenprocurement by the UN
    12. 12. Strategies of the IIATT-SPHS• In order to accomplish the objectives, the IIATT-SPHS has developed a detailed Route Mapinitially facilitated by the SustainableDevelopment Unit of the NHS• The Route Map outlines the strategy,achievements and activities of the different UNAgencies with regard to sustainable procurementin the health sector
    13. 13. • Should we bring in the road map?
    14. 14. Virtuous circle of green procurement in thehealth sectorRelease oftoxic productsResourceconsumption(electricity,water)Greenhousegas emissionsHEALTH CARESYSTEMReduction of GHG emissionsReduction of toxic releasesReduced disease burdenImproved resource efficiencyLesspressure onhealth caresystemImprovedhealthoutcomes andenvironmentalbenefits
    15. 15. Current stage of initiatives• Mapping of existing approaches to:• Environmental criteria in tender processes• Carbon footprinting of pharmaceutical products• Energy efficiency and access to energy and forecastingneeds• Chemical safety and waste management• Corporate social responsibility of suppliers and applicationto their supply chain• Interagency workshops with invited experts/stakeholders• Identification of options for the development of a UN sharedapproach to establishing technical quality standards thatinclude sustainability aspects in the field of pharmaceuticalsand medical devices and articulation of the business case forthe UN and for governments
    16. 16. Concrete initiatives undertaken so far• Carbon footprint assessments:• Pilot projects in Tajikistan and Montenegro• Monthly reporting of carbon footprint of freight• Modification of bidding processes:• Application of the Kaiser Sustainability Scorecard and theSubstitute It Now List developed by ChemSec• Development of organizational strategies forgreen procurement
    17. 17. Timeline of future actionsScoping phase (until the end of 2013)• Mobilize a wide range of stakeholders to build consensus on a set ofcritical priority areas and objectives for sustainable procurementConsensus has been found on putting the main focus of thescoping proposal on the greening aspect of sustainableprocurement• Ensure that the findings of the consultation contribute to thedevelopment of WHO guidelines• Financial contribution of the different agencies:• UNDP: 50,000 USD• UNOPS: 10,000 USD• UNFPA: 10,000 USD• UNICEF: 10,000 USD• Stockholm County Council: approx. 15,000 USD ( 100,000 SEK)• Swedish Medical Agency: approx. 15,000 USD (100,000 SEK)Total: 110,000 USD (approx.)• Technical workshop in Bonn, August 2013
    18. 18. Timeline of future actionsDevelopment of a Joint Programming Proposal• UN initiative to integrate most green procurement activitiesfor the health sector• After the scoping phase there is a 2 years timeframe forguideline development
    19. 19. Main concerns1. Green procurement of pharmaceuticals andmedical products will make the products moreexpensive• Experience in many domains has shown thatsustainability guidelines were providing an innovationpush and often resulted in more cost efficientproduction. In addition sounder financial accountingsystems (such as life cycle costing approaches) allunderline this type of argument• Opportunity for Win-Win
    20. 20. Main concerns2. Green procurement of medicines will createmarket imbalances against manufacturingcompanies from developing countries• Incorrect assumption that manufacturing companiesfrom developing countries are less inclined towardsinnovation• Innovative financing is evidenced by recent offersfrom IFC and Gates Foundation (limited to companiesfrom emerging markets)
    21. 21. Main concerns3. Sustainable product of medicines will reducethe quality and efficacy of the therapydepriving patients of the most effectivetreatment• The potential substitution of medicines by less toxicpharmaceuticals will happen only if the clinical valuefor the patient is the same• Substitution options exist to improve sustainability ofthe manufacturing process e.g. use of solvents inprocessing, energy efficiency and water conservation
    22. 22. Main concerns4. Scientific evidence justifying greenprocurement of pharmaceuticals andmedical devices is insufficient• Existing examples of frameworks for sustainableprocurement in health sector• Montreal Protocol for the phase-out of HFCs and CFCs• Minamata Convention for the phase-out of mercury-containingmedical devices by 2020• Application of the Precautionary Principle• Beyond clinical evidence of effectiveness of medicines, wealso need to take evidence of toxicity into account– sincethere is a need to add long-term impacts of GHG, as well asenvironmental contamination of active ingredient andwaste
    23. 23. Concluding remarksThe IIATT-SPHS targets the emerging environmentalproblems of the health sector:• Green house gas emissions• Toxicity of pharmaceuticals and medical devices to theenvironment and human healthThe IIATT-SPHS envisions to:• Influence the normative level through guidelinedevelopment• Apply a market shaping approach by the formulation oftender processes• Develop a consensus for monitoring and auditingcompliance to sustainability criteria of suppliers and usersof health products and services
    24. 24. Thank you for yourattention

    ×